title: Ceftazidime with β-lactamase inhibitor approved for complicated infections.
authors: Cheryl A
authors: CA
authors: Thompson
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D053961:Azabicyclo Compounds / Q000627:therapeutic use*; D002442:Ceftazidime / Q000627:therapeutic use*; D018795:Device Approval; D004338:Drug Combinations; D006801:Humans; D007239:Infections / Q000150:complications / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration; D065093:beta-Lactamase Inhibitors / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D053961:Azabicyclo Compounds; D004338:Drug Combinations; C000595613:avibactam, ceftazidime drug combination; D065093:beta-Lactamase Inhibitors; D002442:Ceftazidime